REPORT ID 81

China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report Forecast 2017-2021

Publish Date
11-Dec-17
Pages
116
Format
Electronic (PDF)

The China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Non-steroidal Anti-inflammatory Drugs (NSAID) industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Non-steroidal Anti-inflammatory Drugs (NSAID) market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Bayer (DE)
Novacap (FR)
Abbott
Pfizer Inc
Geri-Care Pharmaceuticals
Perrigo Company
Kopran Ltd.
Merck Sharp & Dohme Corp.
Sun Pharmaceutical Industries Ltd
...

China Non-steroidal Anti-inflammatory Drugs (NSAID) Market: Product Segment Analysis
Type 1
Type 2
Type 3 

China Non-steroidal Anti-inflammatory Drugs (NSAID) Market: Application Segment Analysis
Application 1
Application 2
Application 3 

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth 
It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments  
			   
China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report Forecast 2017-2021

Chapter 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segmentation by Type
1.2.1 China Production Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type 1n 2016
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segmentation by Application
1.3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Share by Application in 2016
1.3.2 Application 1 
1.3.3 Application 2
1.3.4 Application 3
1.4 China Market Size Sales (Value) and Revenue (Volume) of Non-steroidal Anti-inflammatory Drugs (NSAID) (2012-2021) 

Chapter 2 China Economic Impact on Non-steroidal Anti-inflammatory Drugs (NSAID) Industry
2.1 China Macroeconomic Environment Analysis
2.1.1 China Macroeconomic Analysis
2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Non-steroidal Anti-inflammatory Drugs (NSAID) Industry

Chapter 3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers
3.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production and Share by Manufacturers (2015 and 2016)
3.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution, Production Area and Product Type
3.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation and Trends
3.5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate
3.5.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Capacity, Production and Growth (2012-2017)
4.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth (2012-2017)
4.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Consumption, Export and Import (2012-2017)

Chapter 5 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue (Value), Price Trend by Type
5.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production and Market Share by Type (2012-2017)
5.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2012-2017)
5.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2012-2017)
5.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Growth by Type (2012-2017)

Chapter 6 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis by Application
6.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption and Market Share by Application (2012-2017)
6.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

Chapter 7 China Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Analysis
7.1 Bayer (DE)
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Product Type, Application and Specification
7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Business Overview
7.2 Novacap (FR)
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Product Type, Application and Specification
7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Business Overview
7.3 Abbott
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Product Type, Application and Specification
7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Business Overview
7.4 Pfizer Inc
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Product Type, Application and Specification
7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Business Overview
7.5 Geri-Care Pharmaceuticals
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Business Overview
7.6 Perrigo Company
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Product Type, Application and Specification
7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Business Overview
7.7 Kopran Ltd.
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Product Type, Application and Specification
7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Business Overview
7.8 Merck Sharp & Dohme Corp.
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Business Overview
7.9 Sun Pharmaceutical Industries Ltd
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Business Overview
?

Chapter 8 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Analysis
8.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs (NSAID) Major Manufacturers in 2015
9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

Chapter 12 China Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast (2017-2021)
12.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue Forecast (2017-2021)
12.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Consumption Forecast by Regions (2017-2021)
12.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Production Forecast by Type (2017-2021)
12.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast by Application (2017-2021)
12.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast (2017-2021)

Chapter 13 Appendix